The erythropoietin receptor

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 10, 1999, Pages 1001-1005

  Tilbrook, Peta A ^a   Klinken, S Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STAT5 PROTEIN;

ARTICLE; ERYTHROCYTE; ERYTHROCYTOSIS; ERYTHROID CELL; GENETIC TRANSCRIPTION; HUMAN; MOUSE; MUTATION; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; POLYCYTHEMIA; RECEPTORS, ERYTHROPOIETIN;

EID: 0032849883     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00071-0     Document Type: Article

References (26)

1. D'Andrea A.D., Lodish H.F., Wong G.G. Expression cloning of the murine erythropoietin receptor. Cell. 57:1989;277-285.
2. D'Andrea A.D., Yoshimura A., Yousoufian H., Zon L.I., Koo J-W., Lodish H.F. The cytoplasmic region of the erythropoietin receptor contains non-overlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11:1991;1980-1987.
3. Watowich S.S. Activation of erythropoietin signalling by receptor dimerization. IJBCB. 31:(10):1999;1075-1087.
4. Tilbrook P.A., Bittorf T., Callus B., Busfield S.J., Ingley E., Klinken S.P. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. Cell Growth Differ. 28:1996;175-181.
5. Wu H., Lui X., Jaenisch R., Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:1995;59-67.
6. Tilbrook P.A., Bittorf T., Busfield S.J., Chappell D., Klinken S.P. Disrupted signaling in a mutant J2E cell line that shows enhanced viability, but does not proliferate or differentiate, with erythropoietin. J. Biol. Chem. 271:1996;3453-3459.
7. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J.N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74:1993;227-236.
8. Chappell D., Tilbrook P.A., Bittorf T., Colley S.M., Meyer G.T., Klinken S.P. Prevention of apoptosis in J2E erythroid cells by erythropoietin: involvement of JAK2 but not MAP kinases. Cell Death Differ. 4:1996;105-113.
9. Tilbrook P.A., Ingley E., Williams J.H., Hibbs M.L., Klinken S.P. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. EMBO J. 16:1997;1610-1619.
10. Chin H., Arai A., Wakao H., Kimayama R., Miyasaka N., Miura O. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the STAT5 pathway. Blood. 91:1998;3734-3745.
11. Damen J.E., Wakao H., Miyajima A., Krosl J., Humphries R.K., Cutler R.L., Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:1995;5557-5568.
12. Ihle J.N. Cytokine receptor signalling. Nature. 377:1995;591-594.
13. Krystal G. SHIPS Ahoy. IJBCB. 31:(10):1999;1007-1010.
14. Klingmuller U., Wu H., Hsiao J.G., Toker A., Duckworth B.C., Cantley L.C., Lodish H.F. Identification of a novel pathway important for prolliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. USA. 94:1997;3016-3021.
15. Koury M.J., Bondurant M.C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 248:1990;378-381.
16. Silva M., Grillot D., Benito A., Richard C., Nunez G., Fernandez-Luna J.L. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-Xl and Bcl-2. Blood. 88:1996;1576-1582.
17. Gregoli P.A., Bondurant M.C. The roles of Bcl-XL and apopain in the control of erythropoiesis by erythropoietin. Blood. 90:1997;630-640.
18. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
19. Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., Yoshimura A. CIS, a Cytokine Inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood. 89:1997;3148-3154.
20. Wu H., Klingmuller U., Besmer P., Lodish H.F. Interaction of the erythropoietin and stem-cell-factor receptors. Nature. 377:1995;242-246.
21. Hanazono Y., Sakasi K., Nitta H., Yazaki Y., Hirai H. Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor. Biochem. Biophys. Res. Comm. 208:1995;1060-1066.
22. Chin H., Wakao H., Miyajima A., Kimayama R., Miyasaka N., Miura O. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (beta(IL3) and recruitment of STAT5 to possible STAT5-docking sites in beta(IL3). Blood. 89:1997;4327-4336.
23. Jubinsky P.T., Krijanovski O.I., Nathan D.G., Tavernier J., Sieff C.A. The β chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood. 90:1997;1867-1873.
24. Longmore G.D., Lodish H.F. An activating mutation in the murine erythopoietin receptor induces erythroleukemia in mice. A cytokine superfamily oncogene. Cell. 67:1991;1089-1102.
25. de la Chapelle A., Traskelin A-L., Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc. Natl. Acad. Sci. USA. 90:1993;4495-4499.
26. Juvonen E., Ikkala E., Fyhrquist F., Ruutu T. Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood. 78:1991;3066-3069.